DHX57

gene
On this page

Also known as DDX57

Summary

DHX57 (DExH-box helicase 57, HGNC:20086) is a protein-coding gene on chromosome 2p22.1, encoding Putative ATP-dependent RNA helicase DHX57 (Q6P158). Probable ATP-binding RNA helicase.

Enables RNA binding activity.

Source: NCBI Gene 90957 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 257 total
  • Dosage sensitivity (ClinGen): haploinsufficiency no evidence, triplosensitivity no evidence
  • MANE Select transcript: NM_198963

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20086
Approved symbolDHX57
NameDExH-box helicase 57
Location2p22.1
Locus typegene with protein product
StatusApproved
AliasesDDX57
Ensembl geneENSG00000163214
Ensembl biotypeprotein_coding
Entrez90957

Gene structure

Transcript identifiers

Ensembl transcripts: 20 — 13 protein_coding, 4 retained_intron, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000442331, ENST00000452978, ENST00000457308, ENST00000474104, ENST00000477981, ENST00000479345, ENST00000492042, ENST00000497514, ENST00000619207, ENST00000620517, ENST00000622155, ENST00000896807, ENST00000896808, ENST00000896809, ENST00000896810, ENST00000934861, ENST00000934862, ENST00000934863, ENST00000934864, ENST00000934865

RefSeq mRNA: 2 — MANE Select: NM_198963 NM_001329963, NM_198963

CCDS: CCDS1800

Canonical transcript exons

ENST00000457308 — 24 exons

ExonStartEnd
ENSE000034695003886099938861837
ENSE000034968853886214538862333
ENSE000035087993885634038856461
ENSE000035158013886336138863519
ENSE000035240913881552138815655
ENSE000035383433880655938806693
ENSE000035649153885866138858836
ENSE000035678853881904938819144
ENSE000036040853882651638826689
ENSE000036055233883783138837947
ENSE000036204093881382138813895
ENSE000036210083880271538802915
ENSE000036232043882299338823269
ENSE000036248993885405438854178
ENSE000036424713882834038828436
ENSE000036454773881887738818960
ENSE000036755733884300538843210
ENSE000036759063884826938848402
ENSE000036779603884701938847073
ENSE000036822473882584738826047
ENSE000037224293887578738875934
ENSE000037389613879772938798442
ENSE000037397353885505738855252
ENSE000037451323886818238868411

Expression profiles

Bgee: expression breadth ubiquitous, 261 present calls, max score 97.98.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.3655 / max 215.3042, expressed in 1755 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
2789411.32201755
278920.03184
278930.00593
278910.00582

Top tissues by expression

282 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001997.98gold quality
buccal mucosa cellCL:000233697.05gold quality
male germ cellCL:000001593.80gold quality
right testisUBERON:000453492.47gold quality
left testisUBERON:000453392.39gold quality
cortical plateUBERON:000534391.51gold quality
ventricular zoneUBERON:000305390.95gold quality
ganglionic eminenceUBERON:000402390.49gold quality
tendon of biceps brachiiUBERON:000818890.14gold quality
testisUBERON:000047389.73gold quality
adenohypophysisUBERON:000219687.33gold quality
monocyteCL:000057687.24gold quality
mononuclear cellCL:000084287.07gold quality
leukocyteCL:000073886.99gold quality
tibiaUBERON:000097986.82gold quality
pituitary glandUBERON:000000786.71gold quality
embryoUBERON:000092286.54gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099185.33gold quality
visceral pleuraUBERON:000240185.31gold quality
stromal cell of endometriumCL:000225585.19gold quality
right uterine tubeUBERON:000130284.99gold quality
sural nerveUBERON:001548884.68gold quality
right adrenal gland cortexUBERON:003582784.39gold quality
granulocyteCL:000009484.32gold quality
left adrenal gland cortexUBERON:003582584.15gold quality
left adrenal glandUBERON:000123484.13gold quality
right lobe of thyroid glandUBERON:000111984.12gold quality
right ovaryUBERON:000211884.11gold quality
hindlimb stylopod muscleUBERON:000425283.97gold quality
adrenal cortexUBERON:000123583.95gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.05

Regulation

Is transcription factor: no

Functional genomics

ClinGen dosage: haploinsufficiency 0 (no evidence), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriodhx57ENSDARG00000057660
mus_musculusDhx57ENSMUSG00000035051
rattus_norvegicusDhx57ENSRNOG00000054272
drosophila_melanogasterCG1582FBGN0030246

Paralogs (18): DHX33 (ENSG00000005100), YTHDC2 (ENSG00000047188), DHX29 (ENSG00000067248), DHX8 (ENSG00000067596), DHX32 (ENSG00000089876), DHX35 (ENSG00000101452), DHX40 (ENSG00000108406), DHX15 (ENSG00000109606), HELB (ENSG00000127311), DHX30 (ENSG00000132153), DHX34 (ENSG00000134815), DHX9 (ENSG00000135829), DHX38 (ENSG00000140829), DQX1 (ENSG00000144045), DHX37 (ENSG00000150990), TDRD9 (ENSG00000156414), DHX36 (ENSG00000174953), DHX16 (ENSG00000204560)

Protein

Protein identifiers

Putative ATP-dependent RNA helicase DHX57Q6P158 (reviewed: Q6P158)

Alternative names: DEAH box protein 57

All UniProt accessions (5): A0A087WW12, A0A087WZ11, Q6P158, H7BZ23, H7C109

UniProt curated annotations — full annotation on UniProt →

Function. Probable ATP-binding RNA helicase.

Similarity. Belongs to the DEAD box helicase family. DEAH subfamily.

Isoforms (3)

UniProt IDNamesCanonical?
Q6P158-11yes
Q6P158-22
Q6P158-33

RefSeq proteins (2): NP_001316892, NP_945314* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000571Znf_CCCHDomain
IPR001650Helicase_C-likeDomain
IPR002464DNA/RNA_helicase_DEAH_CSConserved_site
IPR006575RWD_domDomain
IPR007502Helicase-assoc_domDomain
IPR009060UBA-like_sfHomologous_superfamily
IPR011545DEAD/DEAH_box_helicase_domDomain
IPR011709DEAD-box_helicase_OB_foldDomain
IPR014001Helicase_ATP-bdDomain
IPR015940UBADomain
IPR027417P-loop_NTPaseHomologous_superfamily
IPR036855Znf_CCCH_sfHomologous_superfamily
IPR042615DHX57_UBADomain
IPR048333HA2_WHDomain
IPR059023RNA_hel_CTDDomain

Pfam: PF00270, PF00271, PF00642, PF04408, PF05773, PF07717, PF21010, PF26026

Catalyzed reactions (Rhea), 1 shown:

  • ATP + H2O = ADP + phosphate + H(+) (RHEA:13065)

UniProt features (29 total): modified residue 5, splice variant 5, compositionally biased region 4, domain 3, sequence variant 3, sequence conflict 2, region of interest 2, chain 1, binding site 1, zinc finger region 1, coiled-coil region 1, short sequence motif 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6P158-F176.680.39

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (1): 567–574

Post-translational modifications (5): 127, 132, 475, 477, 480

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 125 (showing top): CCAWYNNGAAR_UNKNOWN, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, CACCAGC_MIR138, ACTGCAG_MIR173P, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, CAGCAGG_MIR370, AAACCAC_MIR140, RFX1_02, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, CAGCCTC_MIR4855P, GGATCCG_MIR127, GOBP_POSITIVE_REGULATION_OF_TRANSLATION, PARENT_MTOR_SIGNALING_UP, GOBP_REGULATION_OF_TRANSLATION

GO Biological Process (1): positive regulation of translation (GO:0045727)

GO Molecular Function (12): RNA binding (GO:0003723), RNA helicase activity (GO:0003724), helicase activity (GO:0004386), ATP binding (GO:0005524), zinc ion binding (GO:0008270), ATP hydrolysis activity (GO:0016887), RNA polymerase binding (GO:0070063), nucleotide binding (GO:0000166), nucleic acid binding (GO:0003676), protein binding (GO:0005515), hydrolase activity (GO:0016787), metal ion binding (GO:0046872)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
ATP-dependent activity2
binding2
translation1
regulation of translation1
positive regulation of gene expression1
positive regulation of protein metabolic process1
nucleic acid binding1
helicase activity1
ATP-dependent activity, acting on RNA1
catalytic activity, acting on RNA1
nucleic acid conformation isomerase activity1
catalytic activity, acting on a nucleic acid1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
transition metal ion binding1
ribonucleoside triphosphate phosphatase activity1
enzyme binding1
nucleoside phosphate binding1
heterocyclic compound binding1
catalytic activity1
cation binding1

Protein interactions and networks

STRING

3000 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
DHX57DDX54Q8TDD1662
DHX57DDX46Q7L014576
DHX57MLST8Q9BVC4518
DHX57KIF13AQ9H1H9500
DHX57DHX58Q96C10473
DHX57FANCMQ8IYD8467
DHX57DICER1Q9UPY3464
DHX57DDX19AQ9NUU7450
DHX57ARHGEF33A8MVX0447
DHX57STXBP4Q6ZWJ1443
DHX57NHLRC1Q6VVB1427
DHX57DDX60Q8IY21427
DHX57DHX34Q14147426
DHX57DDX1Q92499424
DHX57SCGNO76038418

IntAct

274 interactions, top by confidence:

ABTypeScore
DHX57KRTAP10-7psi-mi:“MI:0915”(physical association)0.720
DHX57KRTAP10-8psi-mi:“MI:0915”(physical association)0.720
DHX57KRTAP10-9psi-mi:“MI:0915”(physical association)0.720
KRTAP10-7DHX57psi-mi:“MI:0915”(physical association)0.720
KRTAP10-8DHX57psi-mi:“MI:0915”(physical association)0.720
KRTAP10-9DHX57psi-mi:“MI:0915”(physical association)0.720
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
NEUROG3GXYLT2psi-mi:“MI:0914”(association)0.640
H1-1RRP8psi-mi:“MI:0914”(association)0.640
NOL12RRP8psi-mi:“MI:0914”(association)0.640
DHX57psi-mi:“MI:0915”(physical association)0.560
DHX57psi-mi:“MI:0915”(physical association)0.560
DHX57KRTAP10-5psi-mi:“MI:0915”(physical association)0.560
DHX57CBX2psi-mi:“MI:0915”(physical association)0.560
DHX57ZNF473psi-mi:“MI:0915”(physical association)0.560
DHX57KRTAP9-4psi-mi:“MI:0915”(physical association)0.560
CEP44DHX57psi-mi:“MI:0915”(physical association)0.560
ZNF473DHX57psi-mi:“MI:0915”(physical association)0.560

BioGRID (328): DHX57 (Two-hybrid), DHX57 (Two-hybrid), DHX57 (Two-hybrid), DHX57 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-1 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), DHX57 (Affinity Capture-MS), DHX57 (Affinity Capture-MS), DHX57 (Affinity Capture-MS), DHX57 (Affinity Capture-MS), DHX57 (Affinity Capture-MS)

ESM2 similar proteins: A0A0P0WGX7, A2BGR3, A3KFM7, A3KMI0, A4IHD2, A4PBL4, A6QQR4, B0R061, D3Z9Z9, D3ZA12, E1B7X9, F4I2H2, F4I9Q5, F4J9M5, F4JTF6, F4K128, F8VPZ5, G5EDG2, O14139, O18017, O42861, P0CQ66, P0CQ67, P32657, P32849, P32863, P40352, P87114, Q03468, Q04692, Q0D622, Q0PCS3, Q0WVW7, Q2NKX8, Q5FWR0, Q60EX7, Q6P158, Q6PGC1, Q7F2E4, Q7Z478

Diamond homologs: A1Z9L3, A2A4P0, B3QAB0, B4JT42, B4PRJ9, B4RC48, B6IVG3, D4A2Z8, F4HYJ7, F4IE66, F4IJV4, F4ILR7, F4IM84, F4JMJ3, F4JRJ6, F4K2E9, F4KGU4, O17438, O22899, O35286, O42643, O42945, O43143, O45244, O46072, O51767, O60231, P0C7L7, P0CE10, P15938, P20095, P24384, P24785, P34305, P34498, P36009, P37024, P43329, P45018, P53131

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 162 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Eukaryotic Translation Initiation720.6×5e-07
Cap-dependent Translation Initiation720.6×5e-07
SARS-CoV-1 modulates host translation machinery720.6×5e-07
Formation of the ternary complex, and subsequently, the 43S complex1020.5×9e-10
Formation of a pool of free 40S subunits1819.2×1e-16
Eukaryotic Translation Elongation718.6×1e-06
SRP-dependent cotranslational protein targeting to membrane1918.1×1e-16
Peptide chain elongation1518.1×1e-13

GO biological processes:

GO termPartnersFoldFDR
negative regulation of DNA recombination540.1×1e-05
chromosome condensation636.1×2e-06
cytoplasmic translation1823.8×3e-17
ribosomal small subunit biogenesis1117.9×6e-09
translational initiation615.4×2e-04
translation1712.5×1e-11
rRNA processing1111.1×9e-07
regulation of alternative mRNA splicing, via spliceosome610.5×2e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

257 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance208
Likely benign16
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

4262 predictions. Top by Δscore:

VariantEffectΔscore
2:38802713:A:AGdonor_loss1.0000
2:38802772:T:Adonor_gain1.0000
2:38802911:CTCAC:Cacceptor_gain1.0000
2:38802915:CCTG:Cacceptor_loss1.0000
2:38806594:AT:Adonor_gain1.0000
2:38806626:G:Cdonor_gain1.0000
2:38816093:A:ACdonor_gain1.0000
2:38816094:C:CCdonor_gain1.0000
2:38816097:AGG:Adonor_gain1.0000
2:38818959:CC:Cacceptor_gain1.0000
2:38818960:CC:Cacceptor_gain1.0000
2:38819045:TTA:Tdonor_loss1.0000
2:38819046:TA:Tdonor_loss1.0000
2:38819047:A:ACdonor_gain1.0000
2:38819047:AC:Adonor_gain1.0000
2:38819048:C:CTdonor_gain1.0000
2:38819048:CC:Cdonor_gain1.0000
2:38819048:CCT:Cdonor_gain1.0000
2:38819048:CCTT:Cdonor_gain1.0000
2:38819048:CCTTA:Cdonor_gain1.0000
2:38819140:GATAC:Gacceptor_gain1.0000
2:38819141:ATAC:Aacceptor_gain1.0000
2:38819142:TAC:Tacceptor_gain1.0000
2:38819143:AC:Aacceptor_gain1.0000
2:38819143:ACC:Aacceptor_loss1.0000
2:38819144:CC:Cacceptor_gain1.0000
2:38819144:CCTAA:Cacceptor_loss1.0000
2:38819145:C:CCacceptor_gain1.0000
2:38819145:CTAAA:Cacceptor_loss1.0000
2:38819146:T:Gacceptor_loss1.0000

AlphaMissense

9068 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:38802853:G:CF1293L1.000
2:38802853:G:TF1293L1.000
2:38802855:A:GF1293L1.000
2:38806582:G:CH1265D1.000
2:38815603:A:GF1175S1.000
2:38823078:C:TG1069D1.000
2:38825978:C:AR961S1.000
2:38825978:C:GR961S1.000
2:38825979:C:AR961M1.000
2:38825979:C:GR961T1.000
2:38826582:G:TA916D1.000
2:38826672:A:GL886P1.000
2:38828379:A:GL867P1.000
2:38828420:A:CF853L1.000
2:38828420:A:TF853L1.000
2:38828422:A:GF853L1.000
2:38855085:C:TG626E1.000
2:38855133:G:TA610D1.000
2:38798396:A:GL1355P0.999
2:38798399:A:GL1354P0.999
2:38798420:A:GL1347P0.999
2:38802890:A:GL1281P0.999
2:38806573:A:GS1268P0.999
2:38806580:G:CH1265Q0.999
2:38806580:G:TH1265Q0.999
2:38806581:T:CH1265R0.999
2:38815602:A:CF1175L0.999
2:38815602:A:TF1175L0.999
2:38815604:A:GF1175L0.999
2:38815621:A:GL1169P0.999

dbSNP variants (sampled 300 via entrez): RS1000008139 (2:38839024 C>T), RS1000053160 (2:38821631 T>C), RS1000085753 (2:38803460 C>G), RS1000120840 (2:38805087 C>T), RS1000124861 (2:38821384 G>A), RS1000152604 (2:38845061 G>A,T), RS1000161155 (2:38827372 G>A), RS1000189556 (2:38848018 G>A,C), RS1000257920 (2:38860154 G>A,C), RS1000281182 (2:38798393 T>C), RS1000350024 (2:38870149 T>C,G), RS1000359558 (2:38839197 T>C), RS1000399898 (2:38865315 G>A,C), RS1000414809 (2:38828732 A>T), RS1000435762 (2:38865064 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST001762_614Obesity-related traits9.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004697estradiol measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

32 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases activity, increases abundance, increases expression3
Valproic Aciddecreases expression, affects expression2
aristolochic acid Idecreases expression1
FR900359decreases phosphorylation1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
potassium chromate(VI)affects cotreatment, decreases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
perfluorooctane sulfonic aciddecreases expression1
CGP 52608increases reaction, affects binding1
Resveratrolaffects cotreatment, increases expression1
Sunitinibdecreases expression1
Air Pollutantsaffects expression, increases abundance1
Amiodaroneincreases expression1
Arsenicincreases abundance, increases expression1
Benzo(a)pyrenedecreases methylation1
Cisplatindecreases expression1
Dichlorodiphenyl Dichloroethyleneincreases expression1
Enzyme Inhibitorsdecreases activity, increases O-linked glycosylation1
Ivermectindecreases expression1
Ozoneaffects expression, increases abundance1
Plant Extractsaffects cotreatment, increases expression1
Ribonucleotidesaffects binding1
Tobacco Smoke Pollutionincreases expression1
Tretinoindecreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideincreases expression1
Aflatoxin B1decreases methylation1
Asbestos, Crocidolitedecreases expression1
Cadmium Chloridedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.